How Sentinel Lymph Node Biopsy is Impacting Adjuvant Radiation Treatment in Gynecologic Cancers
There is increasing use of sentinel lymph node biopsy in gynecologic cancers but how best to integrate this information into post-operative radiation treatment recommendations is not always clear. This includes how to interpret isolated tumor cells, micrometastasis, and macrometastasis.
Category
  • Gynecologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Hypofractionation for Soft Tissue Sarcoma
Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.
Category
  • Hypofractionation
  • Sarcoma
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Collaborative Approaches for Challenging CNS Cases: Neurosurgeons and Radiation Oncologists in Practice
This joint session was developed between the American Society for Radiation Oncology (ASTRO) and the American Association of Neurological Surgeons (AANS).
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Beyond Counting on Our Fingers: The Current State and Future Management of Oligometastatic Lung Cancer
There is a high degree of variability in the management and even the understanding of the oligometastatic state in lung malignancies, or indeed in the context of any solid tumor.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Challenging Cases in Lymphoma - Modern RT for the CAR-T and Advanced Imaging Era
A session of challenging cases in lymphoma with a panel of expert radiation oncologists, including one in private practice, and a lymphoma medical oncologist is presented: (1) Refractory CNS lymphoma – primary or secondary, with plans for, or having completed CAR T-cell therapy.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas
Recently, there have been exciting advances in the treatment of relapsed/refractory (R/R) lymphomas. Historically, the standard-of-care included salvage chemotherapy followed by autologous stem cell transplantation (ASCT). Today, many other salvage options are available.
Category
  • General RO
  • Head and Neck
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results
Radiotherapy plays an important role as a consolidation treatment after systemic therapy, either to shorten the course of systemic therapy and reduce hematological, cardiac and fertility toxicity or to reduce the risk of relapse e.g., for bulky masses.
Category
  • Hematologic
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
The Role of Radiation in Diffuse Large B-cell Lymphoma in Community Practice
This session provides an in-depth discussion of the role of radiation therapy in Diffuse Large B-cell Lymphoma (DLBCL). This is the most common type of lymphoma seen in a community practice, and, with recent advancements in treatment, the role of radiation therapy is evolving.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Management of Brain and Spine Metastases in Community Practice
This session reviews the recent data for the sequence and timing of targeted therapies and immune checkpoint inhibitors and radiation therapy for patients with brain metastases.
Category
  • Central Nervous System
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Practical Elements of a Radiopharmaceutical Program: Findings from ASTRO's Safety White Paper
Despite the rapid advancements, there exists a gap in the integration of radiopharmaceutical therapy within radiation oncology practices.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00

Pages